titlesubmit dateissue date
Now showing items 1-10 of 10
Critically short telomeres and toxicity of chemotherapy in early breast cancer
Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia
Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells.
Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics
When should we order a next generation sequencing test in a patient with cancer?